DocMorris AG (ZRSEF)
USD 39.03
(0.0%)
USD 39.03
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 203.34 Million CHF | 159.55% |
| 2022 | 404.58 Million CHF | -11.52% |
| 2021 | 457.27 Million CHF | 27.2% |
| 2020 | 359.48 Million CHF | 31.59% |
| 2019 | 273.19 Million CHF | 22.47% |
| 2018 | 223.06 Million CHF | 28.49% |
| 2017 | 173.6 Million CHF | 24.49% |
| 2016 | 139.45 Million CHF | 18.48% |
| 2015 | 117.69 Million CHF | -10.8% |
| 2014 | 131.94 Million CHF | -8.82% |
| 2013 | 144.71 Million CHF | 98.26% |
| 2012 | 72.99 Million CHF | 8.43% |
| 2011 | 67.31 Million CHF | 3.22% |
| 2010 | 65.21 Million CHF | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 23.87 Million CHF | 0.0% |
| 2024 Q1 | 23.87 Million CHF | -63.43% |
| 2023 Q3 | 76.25 Million CHF | 12.8% |
| 2023 Q2 | 67.59 Million CHF | -11.97% |
| 2023 FY | 1.05 Billion CHF | 159.55% |
| 2023 Q1 | 76.78 Million CHF | -7.17% |
| 2023 Q4 | 65.26 Million CHF | -14.4% |
| 2022 Q3 | 76.9 Million CHF | -9.49% |
| 2022 FY | 404.58 Million CHF | -11.52% |
| 2022 Q1 | 79.15 Million CHF | -45.89% |
| 2022 Q2 | 84.96 Million CHF | 7.35% |
| 2022 Q4 | 82.72 Million CHF | 7.57% |
| 2021 Q2 | 108.04 Million CHF | 5.62% |
| 2021 FY | 457.27 Million CHF | 27.2% |
| 2021 Q1 | 102.28 Million CHF | 0.57% |
| 2021 Q4 | 146.29 Million CHF | 9.77% |
| 2021 Q3 | 133.27 Million CHF | 23.35% |
| 2020 Q3 | 98.09 Million CHF | 30.62% |
| 2020 FY | 359.48 Million CHF | 31.59% |
| 2020 Q4 | 101.7 Million CHF | 3.69% |
| 2020 Q2 | 75.09 Million CHF | -8.97% |
| 2020 Q1 | 82.49 Million CHF | 43.18% |
| 2019 FY | 273.19 Million CHF | 22.47% |
| 2019 Q1 | 60.88 Million CHF | 6.28% |
| 2019 Q2 | 47.38 Million CHF | -22.17% |
| 2019 Q4 | 57.61 Million CHF | -12.61% |
| 2019 Q3 | 65.92 Million CHF | 39.14% |
| 2018 Q2 | 56.86 Million CHF | 0.0% |
| 2018 FY | 223.06 Million CHF | 28.49% |
| 2018 Q1 | 56.86 Million CHF | 14.2% |
| 2018 Q4 | 57.28 Million CHF | 0.0% |
| 2018 Q3 | 57.28 Million CHF | 0.73% |
| 2017 Q2 | 44.97 Million CHF | 2.76% |
| 2017 Q1 | 43.76 Million CHF | 7.59% |
| 2017 FY | 173.6 Million CHF | 24.49% |
| 2017 Q4 | 49.79 Million CHF | 0.0% |
| 2017 Q3 | 49.79 Million CHF | 10.72% |
| 2016 Q4 | 40.67 Million CHF | 0.0% |
| 2016 Q3 | 40.67 Million CHF | 29.91% |
| 2016 Q2 | 31.31 Million CHF | -7.46% |
| 2016 Q1 | 33.83 Million CHF | -23.32% |
| 2016 FY | 139.45 Million CHF | 18.48% |
| 2015 Q1 | 18.21 Million CHF | -6.8% |
| 2015 Q4 | 44.12 Million CHF | 0.0% |
| 2015 Q3 | 44.12 Million CHF | 142.29% |
| 2015 FY | 117.69 Million CHF | -10.8% |
| 2015 Q2 | 18.21 Million CHF | 0.0% |
| 2014 Q2 | 20.2 Million CHF | 0.0% |
| 2014 Q1 | 20.2 Million CHF | -20.62% |
| 2014 Q4 | 19.54 Million CHF | 0.0% |
| 2014 FY | 131.94 Million CHF | -8.82% |
| 2014 Q3 | 19.54 Million CHF | -3.29% |
| 2013 Q2 | 21.96 Million CHF | 0.0% |
| 2013 Q3 | 25.45 Million CHF | 15.87% |
| 2013 Q4 | 25.45 Million CHF | 0.0% |
| 2013 FY | 144.71 Million CHF | 98.26% |
| 2013 Q1 | 21.96 Million CHF | 0.0% |
| 2012 FY | 72.99 Million CHF | 8.43% |
| 2011 FY | 67.31 Million CHF | 3.22% |
| 2010 FY | 65.21 Million CHF | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3437.19 USD | -5916011.708% |
| Allstar Health Brands, Inc. | 215.74 Thousand USD | -94152.991% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | -268.106% |
| Café Serendipity Holdings, Inc. | 1.43 Million USD | -14057.865% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 47.57 Thousand USD | -427371.095% |
| HealthWarehouse.com, Inc. | 13.79 Million USD | -1374.007% |
| LIGAND PHARMACEUTICAL INC | 78.2 Million USD | -160.019% |
| MedGen, Inc. | 16.59 USD | -1225726241.169% |
| Omni Health, Inc. | 1.14 Million USD | -17628.282% |
| Oxford Investments Holdings Inc. | 373.76 Thousand USD | -54305.89% |
| Pineapple, Inc. | 452.94 Thousand USD | -44794.337% |
| ScripsAmerica, Inc. | 31.4 Million USD | -547.515% |